Akèy › Sendwòm myelodisplastik › Illinois › Decatur
Etid klinik pou Sendwòm myelodisplastik nan Decatur, IL
3 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Decatur (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Cancer Care Specialists of Illinois - Decatur, Decatur
- Decatur Memorial Hospital, Decatur
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Ap rekriteFaz 1/2
- Research Site, Decatur
Etid Sendwòm myelodisplastik nan lòt vil
- Houston, TX43 etid
- Baldwin Park, CA26 etid
- New York City, NY21 etid
- Seattle, WA21 etid
- Washington, DC20 etid
- Boston, MA19 etid
- Tampa, FL19 etid
- Miami, FL17 etid
- Columbus, OH14 etid
- Durham, NC14 etid
- Chicago, IL13 etid
- Atlanta, GA13 etid
Lòt etid nan Decatur
- Kansè Poumon ki pa ti selil14 etid
- Kansè pwostat12 etid
- Kansè poumon10 etid
- Kansè nan tete8 etid
- Kansè renn (Kasinom selil renn)7 etid
- Karsinòm selil skuamèz tèt ak kou7 etid
- Leksemi mieloïd egi7 etid
- Kansè vejik6 etid
- Kansè pankreyas6 etid
- Kansè kolorektal6 etid
- Melanom5 etid
- Kansè bouch5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.